Under construction – not a live service
Sign in
Taking people in NorwayNo phase

Compares two keyhole weight-loss operations in adults with severe obesity

Compares a stomach and intestine bypass with stomach reduction in adults with obesity.

Plain-language title generated from the registry record
Registry title: Laparoscopic Single Anastomosis Sleeve Ileal Bypass Versus Laparoscopic Sleeve Gastrectomy for Morbid Obesity

Key facts

Where
Oslo and Tønsberg, NorwaySee the 2 sites

Could this be for you?

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 20 and 60 years old?

Source: NCT05611697, who can take part

Where in Norway

  • Oslo University HospitalOslo, NorwayTaking people
  • The Morbid Obesity Center, Vestfold Hospital TrustTønsberg, NorwayTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Oslo University Hospital
Trial code
NCT05611697
Record updated
18 May 2026
Original description
This study will compare two bariatric surgical interventions in terms of weight loss, gastroesophageal reflux, and effects on obesity-related comorbid conditions in morbidly obese patients.Read full original descriptionShow less

Laparoscopic Single Anastomosis Sleeve Ileal Bypass Versus Laparoscopic Sleeve Gastrectomy for Morbid Obesity: A Randomized Trial

This study will compare two bariatric surgical interventions in terms of weight loss, gastroesophageal reflux, and effects on obesity-related comorbid conditions in morbidly obese patients.

Inclusion: Morbid obesity at referral for bariatric surgery (i.e. a body-mass index [BMI] of ≥35 kg/m2 with obesity-related comorbid conditions or ≥40 kg/m2 with or without such comorbidities); Age 20-60 years; Previous failed attempts of weight loss; Norwegian speaking patients.

Exclusion: Previous or current gastroesophageal reflux symptoms with daily use of antireflux medication. Patients are also excluded if preoperative manometry identifies a hiatal hernia (≥4cm in axial length) or if preoperative upper endoscopy identifies esophagitis grade C or D (LA classification), peptic stricture, Barrett's esophagus, or esophageal carcinoma; A history of major abdominal or bariatric surgery (excluding appendectomy, cholecystectomy, and sectio); Established disabling cardiopulmonary disease, ongoing treatment for cancer, long-term steroid use, and conditions believed to be associated with poor adherence after surgery; BMI ≥55 kg/m2; Achalasia; Pregnancy.

ClinicalTrials.gov NCT05611697